BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation

  November 24, 2025

   · 

  12 min read
• Press Releases

  Avenzo Therapeutics Granted Fast Track Designation for AVZO-103, a Potential Best-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate, for the Treatment of Patients with Urothelial Cancer Previously Treated with Enfortumab Vedotin

  November 24, 2025

   · 

  2 min read
• Press Releases

  C2N Diagnostics Awarded Rigorous New York State Department of Health Permit, Expanding Ability to Provide Its Blood Tests to Help Diagnose Alzheimer’s Disease

  November 24, 2025

   · 

  4 min read
• Press Releases

  EMD Serono Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis

  November 24, 2025

   · 

  6 min read
• Press Releases

  PharmaEssentia Announces Publication of Phase 3 SURPASS-ET Results in The Lancet Haematology

  November 24, 2025

   · 

  7 min read
• Press Releases

  Janux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC

  November 24, 2025

   · 

  4 min read
• Press Releases

  MindImmune Extends Series A to $30M to Advance Inflammation-Focused Alzheimer’s Therapy into the Clinic and Appoints Isaac Stoner as CEO

  November 24, 2025

   · 

  2 min read
• Press Releases

  Readout of Phase 3 Semaglutide Trials Marks Critical Moment in Alzheimer’s Research and Suggests Potential for Combination Therapies

  November 24, 2025

   · 

  3 min read
• Press Releases

  Made Scientific and Cellergy Therapeutics Announce Manufacturing Partnership to Advance First-in-Human Mitochondrial Therapy

  November 24, 2025

   · 

  3 min read
• Press Releases

  Cordance Medical Announces an Oversubscribed $8M Seed Financing to Advance Focused Ultrasound Platform for Brain Disease Treatment

  November 24, 2025

   · 

  2 min read